Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance

Nuwellis IncTrade
YieldMax Magnificent 7 Fund of Option Income ETFsTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.2. Which is the better fit depends on your goals.

NUWEYMAG
Market Cap
$2.50M
Sector
TechnologyIncome / Options Overlay
52-Week High
$164.50$15.98
52-Week Low
$0.73$10.76
Enterprise Value
-$1.21M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.

While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.

YieldMax Magnificent 7 Fund of Option Income ETFs

YMAG trades at $11.26, down slightly (-0.18%) on the day. The technical outlook is bullish with moving averages supporting upward momentum, though oscillators remain neutral. The ETF maintains a consistent weekly dividend distribution strategy, with recent payouts ranging from $0.07 to $0.11 per share. Recent news highlights YieldMax's ongoing distribution announcements and trading activity, with the stock showing 2.7% gains in recent sessions according to Defense World (August 4, 2026).

The outlook remains positive given the bullish technical signals and consistent income generation through dividends. However, investors should monitor NAV stability during earnings periods as noted by Seeking Alpha (July 28, 2026). Key risks include option strategy execution and market volatility affecting the underlying Magnificent 7 components. The ETF's performance remains tied to successful option income generation and component stock stability.

Returns comparison

Trailing returns across standard periods

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE

About YieldMax Magnificent 7 Fund of Option Income ETFs

YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.

Read more on YMAG